SYT1

Across TCGA pan-cancer cohorts, SYT1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SYT1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SYT1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types SYT1 is over-expressed in tumor, although a few such as COAD and PDAC show the opposite, repressed pattern.

COAD, PDAC, and LSCC are the cancer types where SYT1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SYT1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	−1.672	<.001	9	view →
PDAC	All	II,III,IV	−1.172	<.001	6	view →
LSCC	All	All	+0.373	.002	2	view →
LUAD	Female	All	−0.393	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

SYT1–COAD

Open the COAD breakdown →